Banner
Late-Breaking Analysis In Hypertension Shows That Antihypertensive Treatments Differ In Their Ability To Preserve Lives

STOCKHOLM, August 30, 2010 /PRNewswire/ -- According to the results of a late-breaking analysis...

Clinical Results For New Treatment Of Bacterial Vaginosis Infection

The Swedish company Laccure AB recently got CE marking as a Class IIa medical device product for...

88 Percent Of UK Doctors Believe Whiplash Claims Are Exaggerated

AXA, a UK car insurer, has surveyed UK doctors as part of its ongoing campaign to understand the...

On Facebook, Women Are More Plentiful But Men Are Better Ad Targets

Global digital marketing companies Resolution Media and Kenshoo Social published a new report today...

User picture.
Anna OhldenRSS Feed of this column.

Media Relations Executive, PR Newswire Europe... Read More »

Blogroll

DUBLIN, February 5 /PRNewswire/ -- Web based trading company, gsmExchange.com has been commissioned by Vodafone to develop a business-to-business platform that enhances the purchase and distribution of mobile handsets worldwide.

Vodafone, expressed a need for an intra-company-platform that would help them gain a competitive edge. This platform will ensure that Vodafone operating companies coming across unexpected high demands for particular handsets will have an internal exchange or channel to turn to when sourcing stock to meet these demands. In turn, Vodafone operating companies that find themselves over stocked use this site to promote their stock to other Vodafone operating company's world wide.

PLANEGG-MARTINSRIED, Germany, February 5 /PRNewswire/ -- The Martinsried drug discovery and development company 4SC AG (Frankfurt, Prime Standard: VSC) and the Wuppertal-based AiCuris GmbH & Co KG today announced that they have entered into a research collaboration. The long-term goal of this collaboration is to jointly set-up a product pipeline with innovative, anti-infective drug candidates.

It has been agreed in a first step that 4SC AG will, within the context of its collaboration business segment, provide extensive resources from its medicinal chemistry to AiCuris, for research purposes. In return 4SC AG is to receive relevant research funds, of an undisclosed amount, which are to be used for further development of its own project pipeline.

VIENNA, Austria, February 5 /PRNewswire/ -- A workshop organized by the International Scientific Working Group on Tick-Borne Encephalitis (ISW-TBE), held in Baden/Vienna, aims at raising public awareness of TBE and informs on the effectiveness of vaccination. Tick-borne encephalitis, a viral disease transmitted by infected ticks, can leave infected persons with permanent sequelae. The case fatality rate is 1-2%.

Event tourism and TBE

EINDHOVEN, Netherlands and CAMBRIDGE, England, February 5 /PRNewswire/ --

- Agreement Includes ARM Cortex-M3 Processor for Microcontrollers

NXP Semiconductors, the independent semiconductor company founded by Philips, and ARM (LSE:ARM); (Nasdaq:ARMHY) today announced that they have expanded their strategic relationship with a new licensing agreement, including the high-performance, low-power ARM(R) Cortex(TM)-M3 processor, as well as other ARM technology. NXP will introduce a new family of microcontrollers based on the ARM Cortex-M3 processor starting in 2008, further expanding its broad portfolio of 56 ARM7(TM) and ARM9(TM) family-based MCUs.

Minneapolis, February 5 /PRNewswire/ --

- Designed for High Security, Reliable Connectivity and Cost Efficiencies.

Multi-Tech(R) Systems, Inc., a leading data communications and telecommunications technology manufacturer based in Minneapolis, Minnesota, and Symstream(TM) Technology Group Ltd., an Australian-based wireless technology company, announced today an alliance to deliver a wireless modem solution that enables wireless transaction services utilizing the GSM/3g networks.

(Logo: http://www.newscom.com/cgi-bin/prnh/20040505/MTSLOGO)